LON:INS Instem (INS) Share Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range 830▼ 83052-Week Range N/AVolume3,800 shsAverage Volume85,542 shsMarket Capitalization£199.62 millionP/E Ratio5,928.57Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesInsider TradesStock AnalysisHeadlinesInsider Trades Get Instem alerts: Email Address Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. About Instem Stock (LON:INS)Instem plc, together with its subsidiaries, provides information technology solutions and services to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource system for early phase clinical trials; BioRails for discovery data management; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Cyto Study Manager, a data acquisition and reporting solution. The company also offers computational toxicology products and services; Blur Clinical Annonymization; Logbook ELN, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a windows-based system for non-clinical evaluation studies. In addition, it provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; KnowledgeScan Target Safety Assessment services; SENDTrial, a web based solution that can be accessed through a subscription; and Predict delivers computational models. Further, the company provides Sorcerer Colony Counter; sales and administrative support; training, validation, consultancy, cloud, and safety assessment and regulatory information management software services; software solutions to extract intelligence from research and development related healthcare data; and holds intellectual property rights and investment. It also develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.Read More Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. INS Stock News HeadlinesSeptember 5 at 10:30 PM | tmcnet.comNew England Biolabs® Announces 2024 Passion in Science Awards® RecipientsAugust 1, 2024 | msn.comAfter uproar over hike in Budget, govt reverts to 10% customs duty on lab chemicals, with 1 conditionSeptember 7, 2024 | Porter & Company (Ad)The death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.July 19, 2024 | msn.comSTEM program initially for New Town Native American students allows students from the rest of NDApril 19, 2024 | msn.comThe Best Gravel Bike Shoes of 2024February 13, 2024 | msn.comThe Wrap: Maternal healthcareFebruary 13, 2024 | msn.comINSTEM expands to include all North Dakota Native studentsFebruary 7, 2024 | msn.comCrisprBits' OmiCrisp Tracks Omicron-derived JN.1 Variant in Sewage Samples in BengaluruSeptember 7, 2024 | Porter & Company (Ad)The death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.January 31, 2024 | bizjournals.comAustin tech companies made 20 key hires in JanuaryJanuary 25, 2024 | finance.yahoo.comInstem Enables Clients to Leverage ICH S1B Weight of Evidence GuidelineJanuary 24, 2024 | msn.comScientists in Bengaluru discover means to tackle Covid-19 variantsJanuary 2, 2024 | finance.yahoo.comCDISC Names Chris Decker President and CEODecember 27, 2023 | msn.comBattling persistence in tuberculosis bacteriaDecember 27, 2023 | msn.comIISc finds way to battle persistence in TuberculosisDecember 14, 2023 | finance.yahoo.comCulture, Tradition, STEM and Learning on the LandNovember 28, 2023 | fortune.comSeven years after Elon Musk started The Boring Company, the company only has 2.4 miles of tunnel to show for itNovember 28, 2023 | msn.comNearly £40m raised by London and Cambridge autotech companiesSee More Headlines Receive INS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Instem and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolLON:INS CUSIPN/A CIKN/A Webwww.instem.com Phone+44-1785-825600FaxN/AEmployees500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.14 Trailing P/E Ratio5,928.57 Forward P/E RatioN/A P/E Growth1.89Net Income£3.34 million Net Margins5.50% Pretax MarginN/A Return on Equity6.35% Return on Assets4.62% Debt Debt-to-Equity Ratio3.47 Current Ratio0.95 Quick Ratio0.84 Sales & Book Value Annual Sales£61.63 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow15.25 Book ValueGBX 239 per share Price / BookN/AMiscellaneous Outstanding Shares24,050,000Free FloatN/AMarket Cap£199.62 million OptionableNot Optionable Beta0.42 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Phil J. Reason (Age 61)CEO & Executive Director Comp: $300kMr. Nigel John Goldsmith (Age 61)CFO, Secretary & Executive Director Comp: $166kMs. Marybeth ThompsonChief Operating OfficerDr. Gordon Smith BaxterChief Scientific OfficerMr. Mark Poggi M.B.A.Ph.D., Executive Vice President of Global SalesMs. Eve LeconteChief People & Culture OfficerMr. Mike HarwoodChief Product OfficerMr. Gregor GrantExecutive Vice President of Preclinical SolutionsMr. John LeveilleExecutive Vice President of Clinical Trial AccelerationMore ExecutivesKey CompetitorsKoothLON:KOOCambridge CognitionLON:COGRenalytixLON:RENXInduction Healthcare GroupLON:INHCFeedbackLON:FDBKView All Competitors INS Stock Analysis - Frequently Asked Questions How do I buy shares of Instem? Shares of INS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Instem own? Based on aggregate information from My MarketBeat watchlists, some other companies that Instem investors own include Abeona Therapeutics (ABEO), ARCA biopharma (ABIO), Apollo Investment (AINV), Alico (ALCO), Corindus Vascular Robotics (CVRS), DSS (DSS). This page (LON:INS) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Instem plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Instem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
